N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.43p
   
  • Change Today:
    -0.069p
  • 52 Week High: 3.07
  • 52 Week Low: 0.40
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 3,263,688
  • Market Cap: £3.54m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £52,657
Luke Cairns 142,660 £606

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £637,500
Northern Standard Limited 150,000,000 £637,500
Mathenz Marc Kay 74,000,000 £314,500
Patrick Byrne 43,162,500 £183,441
David Farrier 28,000,000 £119,000
Peel Hunt LLP 7,436,152 £31,604
MYLES MCNULTY 4,000,000 £17,000
Lynchwood Nominees Limited 690,800 £2,936
Barclays Stockbrokers Limited 447,800 £1,903
LR Nominees Limited 311,600 £1,324

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.43p
Change Today -0.069p
% Change -13.97 %
52 Week High 3.07
52 Week Low 0.40
Volume 3,263,688
Shares Issued 832.28m
Market Cap £3.54m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Value
54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Income Not Available
Growth
22.99% above the market average22.99% above the market average22.99% above the market average22.99% above the market average22.99% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 18-Jun-2025

Time Volume / Share Price
16:16 3,200 @ 0.40p
15:59 1,500,000 @ 0.41p
15:51 1,500,000 @ 0.41p
15:44 1,000 @ 0.40p
10:47 2,000 @ 0.50p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page